• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Impax Laboratories - Articles and news items

nasal-spray

FDA approves ZOMIG Nasal Spray migraine treatment for use in the US in paediatric patients

Industry news / 17 June 2015 / Victoria White

The FDA has approved ZOMIG Nasal Spray for use in the US in paediatric patients 12 years of age and older for the treatment of migraine with or without aura…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +